FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

FDA Oks Sanofis Hemophilia A Drug

FDA approves a BLA from Sanofis Bioverativ Therapeutics unit for Altuviiio (efanesoctocog alfa), a recombinant DNA-derived, factor VIII concentrate in...

latest-news-card-1
Human Drugs

Ivermectin Not Effective in Treating Covid: Study

A JAMA study that looked at ivermectin as a therapy for treating adult outpatients with mild to moderate Covid-19 finds that the drug does not reduce ...

Medical Devices

FDA Updates Examples of Medical Device Misconnections

FDA adds a new case study to its Examples of Medical Device Misconnections Web page.

latest-news-card-1
Medical Devices

FDA Exploring New Device Active Surveillance System

FDA posts a sources sought information request that seeks potential contractors who may be able to develop and implement a medical device active surve...

latest-news-card-1
Medical Devices

FDA Evaluating Neonatal Incubator Airborne Chemicals

FDA says it is evaluating reports of exposure to airborne chemicals that may be associated with the use of neonatal incubators.

latest-news-card-1
Human Drugs

USPTO Should Check Keytruda Patent Requests: Lawmakers

Four Democrat senators and representatives say the U.S. Patent and Trademark Office should weigh a new Merck patent request for a subcutaneous formula...

latest-news-card-1
Human Drugs

Amneal Pharmaceuticals FDA-483 Released

FDA releases the form FDA-483 issued following an inspection at the Ahmedabad, India-based Amneal Pharmaceuticals Private Limited parenteral manufactu...

latest-news-card-1
Biologics

Lessons Learned from Covid Vaccine Development

CBER director Peter Marks discusses four lessons learned from the rapid development of Covid-19 vaccines and the implications for the future.

latest-news-card-1
Federal Register

Asacol Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Allergans Asacol HD (mesalamine) delayed-release tablet, 800 mg, was not withdrawn due to safety or effec...

latest-news-card-1
Federal Register

Topamax Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determined that Janssens Topamax (topiramate) sprinkle capsules, 50 mg, was not withdrawn due to safety or effectiveness ...